Skip to content

Diet Intervention, Head and Neck Cancer, Feasibility

Improving Dietary Patterns in Head and Neck Cancer Survivors to Optimize Disease Outcomes and Supportive Care: A Pilot/Feasibility Intervention Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03013699
Enrollment
23
Registered
2017-01-06
Start date
2015-01-31
Completion date
2016-09-30
Last updated
2017-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Head and Neck Cancer

Keywords

diet, nutrition, survival, recurrence, cruciferous, dark leafy greens

Brief summary

This study will examine the effects of a dietary intervention in post-treatment head and neck cancer survivors on the ability to function physically, tiredness, and quality of life, as well as on changing markers in the blood that are associated with better recurrence and survival.

Interventions

BEHAVIORALCruciferous and Dark Leafy Green Intervention

Participants receive individual dietary counseling from a Registered Dietitian who will focus on increasing intake of cruciferous and green leafy vegetables while addressing any disease- and treatment-related eating difficulties experienced by the participant.

Participants receive standard educational materials that focus on healthy eating for cancer survivors and the opportunity to briefly discuss nutrition-related concerns with the Registered Dietitian weekly.

Sponsors

University of Alabama at Birmingham
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Patients will be eligible to participate if they are 1) diagnosed with Stage I - IV oral, hypopharyngeal, nasopharyngeal, oropharyngeal, or laryngeal cancer; 2) age 19+; 3) at least 6 months - 2 years post-treatment; 4) able to consume foods orally; 5) no evidence of disease; 6) English-speaking

Exclusion criteria

Patients will not be eligible to participate if they have 1) dementia or organic brain syndrome; 2) severe emotional distress; 3) active schizophrenia; 3) another diagnosis of cancer in the past five years (not including skin or cervical cancer in situ)

Design outcomes

Primary

MeasureTime frameDescription
QuestionnaireAt conclusion of 12 week study periodParticipant satisfaction
Number of patients excluded or not agreeing to participateBaselineFeasibility measure
Adherence to study protocol activities (research records and diet intake self-report)Throughout 12 week study periodFeasibility measure (e.g., percent of assessments completed, percent of counseling phone calls completed, servings of cruciferous vegetables eaten, etc.)
Attrition ratesThroughout 12 week study periodFeasibility measure
Adverse events with reporting according to institutional review board policyThroughout 12 week study period

Secondary

MeasureTime frameDescription
DNA methylationAt beginning and end of 12 week study period
Serum cytokinesAt beginning and end of 12 week study period
Quality of life (assessed using the Functional Assessment of Cancer Therapy Head and Neck index)At beginning and end of 12 week study period
Total energy and nutrient intakesAt beginning and end of 12 week study period
CovariatesAt beginning of 12 week study periodA questionnaire will collect a set of covariates used in the analyses (i.e., these do not represent individual outcomes; this is a group of covariates used in the data analyses). This group includes demographic characteristics (age, sex, race, ethnicity, education, income); lifestyle behaviors (tobacco use, alcohol consumption, exercise); medical history; cancer-specific clinical variables (tumor site, cancer stage, treatment modality); anthropometrics (height and weight)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026